Cybin to participate in the lytham partners 2025 investor healthcare summit on january 13, 2025

Toronto--(business wire)--cybin inc. (nyse american:cybn) (cboe ca:cybn) (“cybin” or the “company”), a clinical-stage breakthrough neuropsychiatry company committed to revolutionizing mental healthcare by developing new and innovative next-generation treatment options, is pleased to announce that doug drysdale, cybin's chief executive officer, will participate in a fireside chat at the lytham partners 2025 investor healthcare summit taking place virtually on january 13, 2025. the fireside chat.
CYBN Ratings Summary
CYBN Quant Ranking